销售和管理费用 更改
Baxter International USD 728M 33M 2026-03
Cerus USD 19.33M 1.55M 2024-12
Dr.Reddys Laboratories INR 26.92B 482M 2025-12
Haemonetics USD 109.15M 7.54M 2025-12
Infinity Pharmaceuticals USD 3.75M 2.19M 2023-06
Northwest Biotherapeutics USD 7.07M 1.06M 2025-09
Plus Therapeutics USD 3.49M 559K 2025-12
Sanofi EUR 2.33B 419M 2026-03
Starpharma Holdings AUD 4.42M 2.86M 2025-12
Sun Pharmaceuticals INR 24.89B 637.6M 2025-03
Teva Pharmaceutical Industries USD 1000M 120M 2026-03